New Post Public Reply Private Reply Replies (1) Message Board ← Newer Older → stocksonhighalert Dec 5, 2024 at 2:06 PM 85 $DYAI Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology https://finance.yahoo.com/news/dyadic-receive...00271.html Newer Older